Stay updated on Zoetis Press Releases

Sign up to get notified when there's something new on the Zoetis Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Zoetis Press Releases page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A new investor-relations press release has been added announcing that Zoetis executives will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on Sept 14, 2026, with a link to the live webcast and a post-event replay. The entry is titled 'Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference' and is dated September 02, 2026.
    Difference
    0.8%
    Check dated 2026-09-03T18:46:30.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Adds a new press release entry about the FDA EUA for Simparica Trio to treat New World screwworm in dogs and puppies, illustrating expanded veterinary solutions and regulatory progress; accompanying navigation changes reconfigure access to site sections.
    Difference
    2%
    Check dated 2026-08-20T13:46:43.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    A new press release reports UK approval of Portela (relfovetmab injection), a long-acting NGF monoclonal antibody for feline osteoarthritis, approved for easing OA pain with a three-month dosing interval in Leatherhead, UK. This expands Zoetis’ portfolio in the UK market and updates the press releases page with the latest regulatory milestone.
    Difference
    0.9%
    Check dated 2026-08-06T09:40:50.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page gains a new press release entry announcing Portela (relfovetmab) launch in Canada and the European Union, highlighting Portela as the first long-acting anti-NGF monoclonal antibody therapy for cats with up to three months of OA pain relief from a single injection. The entry is titled 'Zoetis Launches Portela® (relfovetmab) in Canada and the European Union' and dated July 22, 2026.
    Difference
    0.9%
    Check dated 2026-07-23T05:46:25.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Two new press releases were added: Zoetis announced its agreement to acquire VitalRADS to expand its Global Diagnostics capabilities with teleradiology, imaging services, and workflow technology. The second release reports the Lenivia (izenivetmab) launch in Canada and the European Union for canine osteoarthritis pain management.
    Difference
    2%
    Check dated 2026-07-15T23:46:58.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Zoetis announces European Commission marketing authorization for Poulvac Procerta HVT-ND, a recombinant vector vaccine that protects chickens against Newcastle disease and Marek's disease with a single dose. The vaccine can be administered in ovo or by injection at hatch.
    Difference
    0.9%
    Check dated 2026-07-08T12:14:22.000Z thumbnail image

Stay in the know with updates to Zoetis Press Releases

Enter your email address, and we'll notify you when there's something new on the Zoetis Press Releases page.